De marca
Cyclessa ya no se vende con receta.
Nombre genérico: desogestrel and ethinyl estradiol
Se usa para: Prevenir el embarazo (anticonceptivo)
Pregunte el precio sin seguro
Desogestrel and ethinyl estradiol genérico
Ninguna de las farmacias que revisamos publica su precio.
Un genérico regular tiene el mismo ingrediente activo que Cyclessa, y la FDA exige que funcione de la misma manera.
Cyclessa ya no se vende con receta.
Antes se vendía uno, pero ya no.
El mismo ingrediente activo que Cyclessa. Los rellenos y colorantes pueden variar.
Una compañía vende un genérico de Cyclessa que la FDA califica como sustituto. La farmacia surte el que tenga. Para recibir el de un fabricante en particular, pídalo por su nombre; la mayoría de las farmacias lo pueden pedir en uno o dos días.
Contiene lactosa · Contiene colorantes: FD&C Red No. 40, FD&C Yellow No. 6 · Se vende como Velivet Triphasic Regimen · Fabricado por Duramed Pharmaceuticals Inc Sub Barr Laboratories
| Empaque | NDC |
|---|---|
| Caja de 3 | 0555-9051-67 |
Ingredientes inactivos (en inglés, como en la etiqueta): silicon dioxide, hypromellose 2910 (3 mpa.s), hypromellose 2910 (6 mpa.s), lactose monohydrate, polyethylene glycol 400, polyethylene glycol 8000, polysorbate 80, povidone k30, starch, corn, stearic acid, titanium dioxide, alpha-tocopherol, ferric oxide red, ferric oxide yellow, FD&C Red No. 40, FD&C Yellow No. 6, anhydrous lactose, magnesium stearate, microcrystalline cellulose
Quién lo vende: registros de la FDA y de Medicaid, actualizados cada semana. La página, la tarjeta y el programa de cada fabricante vienen de su propio sitio web.
CYCLESSA® Tablets (desogestrel and ethinyl estradiol tablets USP) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and implants, depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates.
TABLE 2: PERCENTAGE OF WOMEN EXPERIENCING AN UNINTENDED PREGNANCY DURING THE FIRST YEAR OF TYPICAL USE AND THE FIRST YEAR OF PERFECT USE OF CONTRACEPTION AND THE PERCENTAGE CONTINUING USE AT THE END OF THE FIRST YEAR, UNITED STATES.
% of Women Experiencing an Unintended Pregnancy within the First Year of Use Method Chance§ Spermicides¶ Periodic abstinence Calendar Ovulation Method Sympto-Thermal# Post-Ovulation
Typical Use†
Perfect Use‡
% of Women Continuing Use at One Year*
Withdrawal
Cap Þ Parous Women
Nulliparous Women
Sponge Parous Women
Nulliparous Women
DiaphragmÞ
Condom β Female (Reality)
Male
Pill
Progestin Only
Combined
IUD Progesterone T
Copper T 380A
LNg 20
Depo-Provera
Norplant and Norplant-2
Female sterilization
Male sterilization
Emergency Contraceptive Pills: Treatment initiated within 72 hours after unprotected intercourse reduces
risk of pregnancy by at least 75%.à Lactational Amenorrhea Method: LAM is a highly effective, temporary method of contraception.è Source: Trussell J, Stewart F, Contraceptive Efficacy. In Hatcher RA, Trussell J, Stewart F, Cates W, Stewart GK, Kowal D, Guest F, Contraceptive Technology: Seventeenth Revised Edition. New York, NY: Irvington Publishers, 1998.
year Among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason ‡ Among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason à The treatment schedule is one dose within 72 hours after unprotected intercourse and a second dose 12 hours after the first dose. The Food and Drug Administration has declared the following brands of oral contraceptives to be safe and effective for emergency contraception: Ovral® (1 dose is 2 white pills), Alesse® (1 dose is 5 pink pills), Nordette® or Levlen® (1 dose is 2 light orange pills), Lo/Ovral ® (1 dose is 4 white pills), Triphasil® or Tri-Levlen® (1 dose is 4 yellow pills) è However, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency or duration of breastfeeds is reduced, bottle feeds are introduced or the baby reaches six months of age
Fuente: la etiqueta de la FDA de Cyclessa (Aspen Global Inc), 29 de abril de 2022. Etiqueta completa de la FDA (PDF, en inglés)
Los precios cambian: confírmelos con la farmacia antes de surtir su receta. drugalt.com/es/drug/cyclessa/